Kevin DAmour - Insider Trading & Ownership

Location
C/O Brooklyn Immunotherapeutics, Inc., 140 58 Th Street, Building A, Suite 2100, Brooklyn, NY
Summary
The estimated net worth of Kevin DAmour is at least $159K dollars as of June 29, 2022. Kevin DAmour is the Chief Scientific Officer of Brooklyn ImmunoTherapeutics, Inc. and owns shares of Ernexa Therapeutics Inc. (ERNA) stock worth about $159K.
Signature
/s/ Kevin D'Amour
All Insider Reports
All Insider Reports

Ownership of Kevin DAmour

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ERNA Ernexa Therapeutics Inc. Chief Scientific Officer $159K Jun 28, 2022

Insider Transactions Reported by Kevin DAmour:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.